HK1052305B - 用於治療變態反應的重組的或純化的多克隆抗體 - Google Patents

用於治療變態反應的重組的或純化的多克隆抗體

Info

Publication number
HK1052305B
HK1052305B HK03104683.1A HK03104683A HK1052305B HK 1052305 B HK1052305 B HK 1052305B HK 03104683 A HK03104683 A HK 03104683A HK 1052305 B HK1052305 B HK 1052305B
Authority
HK
Hong Kong
Prior art keywords
grass
allergen
pollen
polyclonal antibody
recombinant
Prior art date
Application number
HK03104683.1A
Other languages
English (en)
Other versions
HK1052305A1 (en
Inventor
John S Haurum
Kirsten Drejer
Ulrik Gregers Winther Mörch
Original Assignee
Symphogen As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphogen As filed Critical Symphogen As
Publication of HK1052305A1 publication Critical patent/HK1052305A1/xx
Publication of HK1052305B publication Critical patent/HK1052305B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
HK03104683.1A 2000-05-26 2003-07-02 用於治療變態反應的重組的或純化的多克隆抗體 HK1052305B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200000839 2000-05-26
US21198100P 2000-06-16 2000-06-16
PCT/DK2001/000365 WO2001089563A1 (en) 2000-05-26 2001-05-25 Recombinant or purified polyclonal antibodies for treating allergy

Publications (2)

Publication Number Publication Date
HK1052305A1 HK1052305A1 (en) 2003-09-11
HK1052305B true HK1052305B (zh) 2007-10-12

Family

ID=26068829

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03104683.1A HK1052305B (zh) 2000-05-26 2003-07-02 用於治療變態反應的重組的或純化的多克隆抗體

Country Status (13)

Country Link
EP (1) EP1283720B1 (zh)
JP (1) JP2003534290A (zh)
KR (1) KR100831118B1 (zh)
CN (1) CN1437482A (zh)
AT (1) ATE359819T1 (zh)
AU (2) AU2001262067B2 (zh)
CA (1) CA2410586C (zh)
DE (1) DE60127954T2 (zh)
DK (1) DK1283720T3 (zh)
ES (1) ES2282256T3 (zh)
HK (1) HK1052305B (zh)
NZ (1) NZ522605A (zh)
WO (1) WO2001089563A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003041731A2 (en) * 2001-11-13 2003-05-22 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Method to obtain protection against bystander allergen
AU2004203727C1 (en) 2003-01-07 2008-08-21 Symphogen A/S Method for manufacturing recombinant polyclonal proteins
CN100383244C (zh) * 2003-01-07 2008-04-23 西福根有限公司 用于生产重组多克隆蛋白质的方法
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
US8728525B2 (en) 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
EP1753404A1 (en) 2004-05-12 2007-02-21 Baxter International Inc. Microspheres comprising protein and showing injectability at high concentrations of said agent
DK1765294T3 (da) 2004-05-12 2008-11-10 Baxter Int Nukleinsyremikrokugler samt deres fremstilling og afgivelse
US7884085B2 (en) 2004-05-12 2011-02-08 Baxter International Inc. Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
EP1967529A1 (en) 2004-07-20 2008-09-10 Symphogen A/S Anti-rhesus D recombinant polyclonal antibody and methods of manufacture
ATE548657T1 (de) 2004-07-20 2012-03-15 Symphogen As Prozedur zur strukturellen charakterisierung rekombinanter polyclonaler proteine oder einer polyclonalen zelllinie
JP5118139B2 (ja) 2006-08-04 2013-01-16 バクスター・インターナショナル・インコーポレイテッド 新規発症自己免疫性糖尿病を予防および／または逆転させるためのマイクロスフィアに基づく組成物
TW200846362A (en) * 2007-02-09 2008-12-01 Symphogen As A polyclonal antibody product
PL2121920T3 (pl) 2007-03-01 2012-01-31 Symphogen As Sposób klonowania pokrewnych przeciwciał
MX2009011218A (es) 2007-04-17 2010-02-11 Baxter Int Microparticulas de acido nucleico para administracion pulmonar.
JP2011518790A (ja) * 2008-04-23 2011-06-30 シムフォゲン・アクティーゼルスカブ ポリクローナルタンパク質を製造する方法
KR101242797B1 (ko) * 2010-06-08 2013-03-12 아주대학교산학협력단 락토페린 발현 수준 측정 제재를 포함하는 알러지성 비염 진단용 조성물
KR101803187B1 (ko) 2015-05-20 2017-12-01 중앙대학교 산학협력단 돼지풀 추출물을 유효성분으로 함유하는 IL-1β 관련질환 예방 또는 치료용 약학조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1203164A (en) * 1982-03-09 1986-04-15 Thomas J. Mckearn Antibody conjugates
US4740371A (en) * 1984-09-17 1988-04-26 International Institute Of Cellular And Molecular Pathology Treatment of allergy
CA1336818C (en) * 1987-04-16 1995-08-29 International Institute Of Cellular And Molecular Pathology Treatment of allergy and composition thereof
US5512283A (en) * 1990-07-06 1996-04-30 Allergene, Inc. Methods for the selective suppression of an immune response to dust mite der Pi
AU5958494A (en) 1992-12-21 1994-07-19 Tanox Biosystems, Inc. Allergen-specific iga monoclonal antibodies and related products for allergy treatment
DE69534347T2 (de) * 1994-01-31 2006-05-24 Trustees Of Boston University, Boston Bibliotheken aus Polyklonalen Antikörpern
DE69739482D1 (de) * 1996-09-11 2009-08-13 Elizabeth Shanahan-Prendergast Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen

Also Published As

Publication number Publication date
DE60127954D1 (de) 2007-05-31
HK1052305A1 (en) 2003-09-11
KR20030022134A (ko) 2003-03-15
DE60127954T2 (de) 2008-01-17
ES2282256T3 (es) 2007-10-16
NZ522605A (en) 2005-03-24
CN1437482A (zh) 2003-08-20
KR100831118B1 (ko) 2008-05-20
AU6206701A (en) 2001-12-03
CA2410586A1 (en) 2001-11-29
AU2001262067B2 (en) 2005-09-29
CA2410586C (en) 2010-07-20
JP2003534290A (ja) 2003-11-18
DK1283720T3 (da) 2007-08-13
EP1283720A1 (en) 2003-02-19
ATE359819T1 (de) 2007-05-15
WO2001089563A1 (en) 2001-11-29
EP1283720B1 (en) 2007-04-18

Similar Documents

Publication Publication Date Title
HK1052305A1 (en) Recombinant or purified polyclonal antibodies for treating allergy
Gevaert et al. Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue
Holtfreter et al. Towards the immune proteome of Staphylococcus aureus–The anti-S. aureus antibody response
Jaligama et al. Regulatory T cells and IL10 suppress pulmonary host defense during early-life exposure to radical containing combustion derived ultrafine particulate matter
WO2004022718A3 (en) Therapeutic human anti-il-1r1 monoclonal antibody
AU2001272925A1 (en) Use of interleukin-4 antagonists and compositions thereof
WO2002030460A3 (en) Therapeutic antibodies
WO2007028047A3 (en) Immunological uses of immunodulatory compounds for vaccine and anti-infections disease therapy
RU2011151781A (ru) ИММУНОГЕННЫЕ КОМПОЗИЦИИ АНТИГЕНОВ Staphylococcus aureus
DE602004025840D1 (de) Polypeptide enthaltende zusammensetzungen
NO970108D0 (no) Konjugat mellom et modifisert superantigen og en målsökende forbindelse samt anvendelse av konjugaten
WO2004067554A3 (en) Compositions and methods of tolerizing a primate to an antigen
Neimert‐Andersson et al. Carbohydrate‐based particles reduce allergic inflammation in a mouse model for cat allergy
Van Regenmortel et al. Immunochemical studies of tobacco mosaic virus—II: Univalent and monogamous bivalent binding of IgG antibody
Reginald et al. Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1‐specific monoclonal IgE
CA2054551A1 (en) Monoclonal antibodies to mite allergen and the use thereof
CA2609995A1 (en) Non-injection immunotherapy
ATE338819T1 (de) Antigenes protein aus malassezia
Chang et al. Comparison of asthma phenotypes using different sensitizing protocols in mice
Huang et al. Induction of specific Th1 responses and suppression of IgE antibody formation by vaccination with plasmid DNA encoding Cyn d 1
SE9703531D0 (sv) Non-anaphlactic forms of allergens and their use
ATE435032T1 (de) Impstoff gegen yersinia mit einem oder zwei monoklonaler antikörper, die für yersinia pestis f1-antigen und v-antigen spezifisch sind
CN208624684U (zh) 一种保护腕关节的护腕
Kernerman et al. 196 Evidence of cross-reactivity between olive, ash, privet, and Russian olive tree pollens
Esch et al. Allergen immunotherapy

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110525